CIK 0001196298
- Non-accelerated filer
- Smaller reporting company
NEPHROS INC
Sign in to watch- Ticker
- NEPH
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133971809
- Phone
- +1 201-343-5202
- Business address
- 380 LACKAWANNA PLACE, SOUTH ORANGE, NJ, 07079
- 4 Open-market buy Chief Financial Officer bought 20,000 shares at $0.26 ($5,198)
- 4 Open-market buy President and CEO bought 21,461 shares at $0.26 ($5,580)
- 4 Open-market buy President and CEO bought 30,000 shares at $0.26 ($7,650)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 17,756 shares (grant or award)
- 4 Open-market buy Chief Financial Officer bought 166,666 shares
- 4 Open-market buy President and CEO bought 83,332 shares
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award President and CEO acquired 213,068 shares (grant or award)
- 4 Grant or award President and CEO acquired 9,165 shares (grant or award)
- 4 Open-market buy President and CEO bought 4,069 shares at $0.32 ($1,302)
- 4 Open-market buy President and CEO bought 10,620 shares at an average $0.34 ($3,610)
- 4 Open-market buy President and CEO bought 41,530 shares at an average $0.32 ($13,286)
- 4 Grant or award Director acquired 73,864 shares (grant or award)
- 4 Grant or award Director acquired 113,636 shares (grant or award)
- 4 Grant or award Director acquired 73,864 shares (grant or award)
- 4 Grant or award Director acquired 73,864 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 8 of 17 · 332 filings